RecruitingNCT07206628

Real-world Study to Assess Adherence to IOP Lowering Therapy in Glaucoma Patients Using CONNECTDROP®

Real-world Study to Assess Adherence to IOP Lowering Therapy in Glaucoma Patients Using CONNECTDROP®: the GRANITE Study (Glaucoma tReatment AdhereNce wIth connecTed dEvice in Italy)

Sponsor

Laboratoires Thea

Enrollment

200 participants

Start Date

Sep 19, 2025

Study Type

OBSERVATIONAL

Conditions

Adherence to Glaucoma Therapy

Summary

The goal of this real-life, national, multicentre, prospective clinical investigation is to describe the adherence rate over time in patients with glaucoma already treated with IOP-lowering eye drops using connected device CONNECTDROP® The main questions it aims to answer are: * The mean annual adherence rate, defined as the percentage of the prescribed doses taken by the patient * The adherence profile of each patient * The association between the adherence profile, the objective adherence data and the clinical data. Participants will use the connected device CONNECTDROP® associated with the smartphone application on a daily basis.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at whether using a specially designed eye drop bottle system called CONNECTDROP (with an EASYGRIP bottle) can help glaucoma patients take their eye drops more consistently and correctly. Adherence to eye drop medication is a major challenge in managing glaucoma, and this study aims to track and improve it. **You may be eligible if...** - You are 18 or older - You have been diagnosed with bilateral open-angle glaucoma in both eyes - You have been using glaucoma eye drops in the EASYGRIP bottle as a single medication for at least 6 weeks - You are willing to participate and consent to data collection **You may NOT be eligible if...** - You are pregnant or breastfeeding - You are using another eye medication regularly for a separate chronic eye condition - You are under legal guardianship, incarcerated, or otherwise considered a protected patient under French law Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(17)

Besomed SRLS

Bari, Italy

Studio Oculistico D'Azeglio

Bologna, Italy

Centro Medico Polispecialistico Di Maita

Catania, Italy

Studio Medico Oculistico Dr.ssa Rosa SCHIAVELLI s.r.l.

Corigliano, Italy

Ospedale Policlinico S. Martino-IRCCS Clinica Oculistica Università di Genova

Genova, Italy

Poliambulatorio Chirurgico Modenese Eyecare Clinic

Modena, Italy

Centro Oculistico Ramovecchi S.r.l.

Morrovalle, Italy

AOU Federico II di Napoli Dipartimento di Neuroscienze e Scienze Riproduttive ed Odontostomatologiche Università degli studi di Napoli Federico II U.O.C. di Oftalmologia

Naples, Italy

Azienda Ospedale-Università Padova Ospedale Sant'Antonio UOC Oculistica

Padova, Italy

A.O.U. Pisana UO Oculistica Universitaria

Pisa, Italy

Ambulatorio Oculistica Ospedale San Carlo di Nancy -GVM-

Roma, Italy

Fondazione PTV Policlinico Tor Vergata Fondazione PTV Policlinico Tor Vergata UOSD di Oculistica

Roma, Italy

IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS Presidio Ospedaliero Britannico Unità di Ricerca "Glaucoma

Roma, Italy

AULSS 4 Veneto Orientale Ospedale di San Donà di Piave Dip. Oculistica

San Donà di Piave, Italy

AOU Sassari Clinica Oculistica

Sassari, Italy

Studi Oculistici

Seravezza, Italy

Humanitas Gradenigo U.O. Oculistica

Torino, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07206628